Invertor Relations

Shareholder Information

SYMBOL: MYG
Listing: Toronto Stock Exchange (TSX)
View Stock Quote

TRANSFER AGENT
Computershare Trust Company of Canada
1500 University Street, Suite 700
Montreal, Quebec, Canada H3A 3S8

AUDITORS
Ernst & Young LLP
800 René-Lévesque Blvd West, Suite 1900
Montreal, Quebec, Canada H3B 1X9

May 13, 2013	METHYLGENE REPORTS FIRST QUARTER 2013 FINANCIAL RESULTS
May 9, 2013	METHYLGENE ANNOUNCES PLAN TO REINCORPORATE IN THE UNITED STATES AS MIRATI THERAPEUTICS, INC. AND LIST ON THE NASDAQ
April 8, 2013	METHYLGENE PRESENTS PRECLINICAL DATA ON MG516 AT THE AMERICAN ASSOCIATION FOR CANCER RESEARCH ANNUAL MEETING
March 18, 2013	METHYLGENE REPORTS RESULTS OF PHASE II TRIAL OF MGCD290
March 14, 2013	METHYLGENE ANNOUNCES MANAGEMENT CHANGES